Brainlab's robotic imaging device cleared by FDA
Image-guided therapy firm Brainlab announced that its Loop-X mobile imagin...Read more on AuntMinnie.comRelated Reading:
Accuray partners with Brainlab in radiation therapy
IMV: Radiation therapy volume stays steady despite COVID-19
Brainlab launches new spine imaging system
Brainlab gets FDA nod for MR contrast analysis software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 22, 2021 Category: Radiology Source Type: news
Radioactive bone cement found to be safer in treating spinal tumors
(University of California - Irvine) A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news
ASCO Endorses Guidelines on Radiation Therapy for SCLC ASCO Endorses Guidelines on Radiation Therapy for SCLC
The American Society of Clinical Oncology (ASCO) has endorsed guidelines on radiation therapy for patients with small cell lung cancer (SCLC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Penn State Health Purchases Second ViewRay MRIdian(R) Linac
Order is part of a Master Agreement for the Purchase of up to Four MRIdian Systems
CLEVELAND, Feb. 11, 2021 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Penn State Health has purchased a second MRIdian ... Devices, Radiology, Oncology ViewRay, MRIdian, MRI-guided radiation therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2021 Category: Pharmaceuticals Source Type: news
Janssen Announces Treatment with ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the Phase 3 TITAN study, which demonstrated the continued statistically significant benefit of the addition of ERLEADA® (apalutamide) to androgen deprivation therapy (ADT) in overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC), regardless of extent of disease, when compared to placebo plus ADT.[1] Results will be featured in an oral presentation at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cancers Symposiu...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Patients in the trial received either a combination of ERLEADA® and ZYTIGA® plus prednisone (combination arm) or placebo and ZYTIGA® pl...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
IMV: MRI procedure volume fell 35% in 2020
The COVID-19 pandemic most likely led to a 35% drop in MRI procedure volum...Read more on AuntMinnie.comRelated Reading:
IMV: CT procedure volume fell 20% in 2020
IMV: Radiation therapy volume stays steady despite COVID-19
IMV: COVID-19 cuts ultrasound exam volume by 50%
IMV: COVID-19 changes service needs for imaging equipment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2021 Category: Radiology Source Type: news
MRI-targeted biopsy shows value in prostate cancer
Multiparametric MRI-targeted biopsy for clinically significant prostate cance...Read more on AuntMinnie.comRelated Reading:
MRgFUS shows promise for prostate cancer treatment
Hypofractionated radiotherapy helped England survive COVID-19
AI, radiomics predicts prostate cancer recurrence
Radiation therapy takes toll on prostate cancer patients' finances
In a year of pandemic, MRI perseveres (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2021 Category: Radiology Source Type: news
Dartmouth-invented technology allows doctors to see beam field during radiation treatment
(Dartmouth-Hitchcock Medical Center) With the use of the BeamSite Cherenkov imaging camera system invented by DoseOptics, LLC., radiation oncologists at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center can capture real-time external beam delivery images during cancer patients' standard radiation therapy sessions. These images are used to verify that the beam is targeting the exact area intended, and make necessary adjustments to prevent unintentional exposure to patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2021 Category: Cancer & Oncology Source Type: news
Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said Craig Tendler, M...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Providing inclusive care for LGBTQ2SPIA+ cancer patients
(Elsevier) In an upcoming issue of the Journal of Medical Imaging and Radiation Sciences, published by Elsevier, undergraduate researchers from the University of Alberta's Radiation Therapy Program in the Faculty of Medicine and Dentistry describe how LGBTQ2SPIA+ patients face unique cancer risks, including fear of discrimination, higher incidence of certain cancer sites, and lower screening rates, resulting in more cancers detected at later stages. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 2, 2021 Category: International Medicine & Public Health Source Type: news
Canon expands utility of AiCE in MRI
Canon Medical Systems said that its Advanced intelligent Clear-IQ Engine (AiCE...Read more on AuntMinnie.comRelated Reading:
Sales of CT and x-ray help Canon 2020 results
Canon's wide-bore CT for radiation therapy clears FDA
Canon touts wide-bore CT, AI for PET/CT at RSNA 2020
Canon offers guides for ultrasound in COVID-19 patients
Canon 1.5T MRI rivals 3T in head-to-head challenge (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 1, 2021 Category: Radiology Source Type: news
ASTRO endorses COVID-19 vaccine for cancer patients
The American Society for Radiation Oncology (ASTRO) has updated its COVID-19...Read more on AuntMinnie.comRelated Reading:
ASTRO lauds delay of radiation therapy payment reform
Prelude highlights ASTRO data on breast cancer risk test
Race, ethnicity vary in radiation therapy trials
Radiation therapy access grows, but not in rural areas
Small study supports radiation before CAR-T therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 29, 2021 Category: Radiology Source Type: news
Sales of CT and x-ray help Canon 2020 results
Strong sales of CT and x-ray systems helped Canon's medical systems business...Read more on AuntMinnie.comRelated Reading:
Canon's wide-bore CT for radiation therapy clears FDA
Canon touts wide-bore CT, AI for PET/CT at RSNA 2020
Canon offers guides for ultrasound in COVID-19 patients
Canon 1.5T MRI rivals 3T in head-to-head challenge
Avicenna, Canon to partner on AI stroke detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 29, 2021 Category: Radiology Source Type: news
Varian shows mixed results for Q1
Radiation therapy firm Varian Medical Systems posted a 6% drop in revenue but...Read more on AuntMinnie.comRelated Reading:
Varian's revenues slip for Q4, full year
Varian posts lower revenue, net income
COVID-19 affects Varian's Q2 results
Varian posts strong Q1 sales growth as profit slips
Varian posts continued revenue gains in Q4, fiscal 2019 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 27, 2021 Category: Radiology Source Type: news
